MedPath

Comparison of two drugs for assessing the easier insertion conditions of a airway device to give General Anaesthesia

Phase 2
Completed
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2019/12/022209
Lead Sponsor
PIMS Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
85
Inclusion Criteria

Patients admitted to our hospital posted for short surgical procedures coming under American Society of Anaesthesiologists grade I or II.

Mallampati Grade I & II

Surgeries lasting for 1 to 2 hours (like short gynaecologic procedures, Incision and drainage and fibroadenoma excision)

Exclusion Criteria

Emergency surgeries

Patients at the risk of aspiration (hiatus hernia, pregnancy, full stomach, intestinal ileus) Patients with known gastrointestinal reflux, sore throat, upper respiratory airway infections.

Patients suffering from pharyngeal pathology e.g. abscess, haematoma and tissue disruption.

Low pulmonary compliance e.g. morbid obesity, bronchospasm or pulmonary oedema.

Patients undergoing oral surgery and those allergic to propofol, Dexmedetomidine or Butorphanol.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare Butorphanol and Dexmedetomidine as adjuvants to propofol on the insertion conditions of Baska Mask for short proceduresTimepoint: 2 hours
Secondary Outcome Measures
NameTimeMethod
1.The ease of insertion (assessed by the duration of time taken to insert them successfully and the number of insertion attempts)Timepoint: 1 hour <br/ ><br> <br/ ><br> <br/ ><br>;2.To assess the incidence of complications such as laryngospasm during insertionTimepoint: 2 hours;3.To detect the hemodynamic responses induced by airway insertion (blood pressure, heart rate, oxygen saturation and end-tidal carbon dioxide (EtCO2)Timepoint: 2 hours
© Copyright 2025. All Rights Reserved by MedPath